Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy | Zendy

Jae Sik Kim | Zendy; Noorie Choi | Zendy; Il Han Kim | Zendy; Tae Min Kim | Zendy; Yoon Kyung Jeon | Zendy; Ji Hyun Chang | Zendy

Open Access

Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy

Author(s) -

Jae Sik Kim,

Noorie Choi,

Il Han Kim,

Tae Min Kim,

Yoon Kyung Jeon,

Ji Hyun Chang

Publication year - 2022

Publication title -

clinical and translational radiation oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.336

H-Index - 15

ISSN - 2405-6308

DOI - 10.1016/j.ctro.2022.10.014

Subject(s) - medicine , chemotherapy , lymphoma , stage (stratigraphy) , oncology , radiation therapy , nuclear medicine , gastroenterology , urology , paleontology , biology

To assess treatment outcomes in patients with stage I/II extranodal NK-/ T -cell lymphoma, nasal type (ENKTCL-NT) and the feasibility of low-dose radiotherapy (RT) for achieving complete response (CR, defined as showing no residual hypermetabolic uptake on positron emission tomography [PET] or no residual lesions on computed tomography [CT]) after l-asparaginase-containing chemotherapy (l-ASP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research